Advanced strategies for combinational immunotherapy of cancer based on polymeric nanomedicines

Although immunotherapy has revolutionized cancer therapy by providing efficient tumor growth suppression, long-term protection from recurrence as well as minimized side effects, the low response rate significantly limits the clinical application of immunotherapy in board types of solid tumors. In or...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:BMEMat
المؤلف الرئيسي: 2-s2.0-85192825219
التنسيق: Review
اللغة:English
منشور في: John Wiley and Sons Inc 2024
الوصول للمادة أونلاين:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85192825219&doi=10.1002%2fbmm2.12067&partnerID=40&md5=2dc3264ce264ad30452dc06425e3483e
id You K.; Wang Q.; Osman M.S.; Kim D.; Li Q.; Feng C.; Wang L.; Yang K.
spelling You K.; Wang Q.; Osman M.S.; Kim D.; Li Q.; Feng C.; Wang L.; Yang K.
2-s2.0-85192825219
Advanced strategies for combinational immunotherapy of cancer based on polymeric nanomedicines
2024
BMEMat
2
2
10.1002/bmm2.12067
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85192825219&doi=10.1002%2fbmm2.12067&partnerID=40&md5=2dc3264ce264ad30452dc06425e3483e
Although immunotherapy has revolutionized cancer therapy by providing efficient tumor growth suppression, long-term protection from recurrence as well as minimized side effects, the low response rate significantly limits the clinical application of immunotherapy in board types of solid tumors. In order to improve the therapeutic efficacy, conventional therapies including radiotherapy, chemotherapy, phototherapy and chemodynamic therapy are employed to combine with immunotherapy to elicit stronger antitumor immune responses. Polymer nanomedicines are frequently utilized in synergistic immunotherapy and other therapies owing to their tunable physiochemical properties, high drug loading capacity, ease of modification and low toxicity. With elaborate design and tailored properties, polymer nanomedicines can significantly enhance antitumor efficacy by enhancing tumor specificity, priming immune cells and amplifying immune responses in tumors. However, until now, there is no review solely dedicated to the comprehensive development of polymer-based platforms for combinational immunotherapy of cancers. Herein, this paper summarizes latest advances in the design, fabrication and application of polymer nanomedicines in combinational immunotherapy and traditional antitumor strategies including radiotherapy, chemotherapy, photothermal therapy, photodynamic therapy and other therapies. An outlook on the trajectory and potential challenges of polymer nanomedicines in bridging the gap between immunotherapy and conventional therapies is also discussed. © 2024 The Authors. BMEMat published by John Wiley & Sons Australia, Ltd on behalf of Shandong University.
John Wiley and Sons Inc
27517438
English
Review
All Open Access; Gold Open Access
author 2-s2.0-85192825219
spellingShingle 2-s2.0-85192825219
Advanced strategies for combinational immunotherapy of cancer based on polymeric nanomedicines
author_facet 2-s2.0-85192825219
author_sort 2-s2.0-85192825219
title Advanced strategies for combinational immunotherapy of cancer based on polymeric nanomedicines
title_short Advanced strategies for combinational immunotherapy of cancer based on polymeric nanomedicines
title_full Advanced strategies for combinational immunotherapy of cancer based on polymeric nanomedicines
title_fullStr Advanced strategies for combinational immunotherapy of cancer based on polymeric nanomedicines
title_full_unstemmed Advanced strategies for combinational immunotherapy of cancer based on polymeric nanomedicines
title_sort Advanced strategies for combinational immunotherapy of cancer based on polymeric nanomedicines
publishDate 2024
container_title BMEMat
container_volume 2
container_issue 2
doi_str_mv 10.1002/bmm2.12067
url https://www.scopus.com/inward/record.uri?eid=2-s2.0-85192825219&doi=10.1002%2fbmm2.12067&partnerID=40&md5=2dc3264ce264ad30452dc06425e3483e
description Although immunotherapy has revolutionized cancer therapy by providing efficient tumor growth suppression, long-term protection from recurrence as well as minimized side effects, the low response rate significantly limits the clinical application of immunotherapy in board types of solid tumors. In order to improve the therapeutic efficacy, conventional therapies including radiotherapy, chemotherapy, phototherapy and chemodynamic therapy are employed to combine with immunotherapy to elicit stronger antitumor immune responses. Polymer nanomedicines are frequently utilized in synergistic immunotherapy and other therapies owing to their tunable physiochemical properties, high drug loading capacity, ease of modification and low toxicity. With elaborate design and tailored properties, polymer nanomedicines can significantly enhance antitumor efficacy by enhancing tumor specificity, priming immune cells and amplifying immune responses in tumors. However, until now, there is no review solely dedicated to the comprehensive development of polymer-based platforms for combinational immunotherapy of cancers. Herein, this paper summarizes latest advances in the design, fabrication and application of polymer nanomedicines in combinational immunotherapy and traditional antitumor strategies including radiotherapy, chemotherapy, photothermal therapy, photodynamic therapy and other therapies. An outlook on the trajectory and potential challenges of polymer nanomedicines in bridging the gap between immunotherapy and conventional therapies is also discussed. © 2024 The Authors. BMEMat published by John Wiley & Sons Australia, Ltd on behalf of Shandong University.
publisher John Wiley and Sons Inc
issn 27517438
language English
format Review
accesstype All Open Access; Gold Open Access
record_format scopus
collection Scopus
_version_ 1828987859813531648